Eliglustat cerdelga 84MG for VA SD
Ended Awarded Last action
- Contract number
- 36C26223F0045
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $246,001
Award facts
- Contract value 100% obligated
- $246,001.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$14,636 | |
| Original award | $260,637 |
About this award
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Genzyme Corporation, doing business as Sanofi Genzyme, for the pharmaceutical product Eliglustat (Cerdelga 84mg) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) contract. The order has a ceiling value of $246,001.38 and a performance period ending on October 26, 2023. Genzyme serves as the prime contractor, with no set-aside designation applied. This delivery order is one of several Genzyme has received from various VHA Networks (VISNs) and medical centers nationwide for specialty pharmaceutical products like Lemtrada, Caprelsa, and other cancer drugs to support treatment programs for veterans. Genzyme holds two major federal contract IDVs with the VA, including a $659 million multiple award Pharmaceuticals and Drugs FSS-61-IB contract and a $4 million single-award BPA for Lemtrada and Cerdelga, providing the VHA and other federal healthcare agencies efficient access to Genzyme's pharmaceutical portfolio.
Quick answers
Who was awarded contract 36C26223F0045?
36C26223F0045 was awarded to Genzyme Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 27, 2022.
How much is contract 36C26223F0045 worth?
The government has obligated $246,001 on 36C26223F0045.
Is contract 36C26223F0045 an order under another contract?
Yes. 36C26223F0045 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26223F0045 competed?
The extent of competition for 36C26223F0045 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award